Search

Fresenius Medical Care AG

Closed

Sector Healthcare

35.62 -0.45

Overview

Share price change

24h

Current

Min

35.56

Max

35.7

Key metrics

By Trading Economics

Income

116M

187M

Sales

10M

4.7B

P/E

Sector Avg

21.64

EPS

0.7

Profit margin

3.946

EBITDA

56M

830M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+5.36 upside

Dividends

By Dow Jones

Next Earnings

5 Nov 2024

Market Stats

By TradingEconomics

Market Cap

-73M

10B

Previous open

36.07

Previous close

35.62

News Sentiment

By Acuity

50%

50%

278 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Fresenius Medical Care AG Chart

Related News

11 Oct 2023, 09:38 UTC

Major Market Movers

Fresenius Shares Slump After Novo Nordisk Kidney Disease Trial Shows Efficacy

15 Jul 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3 May 2024, 08:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Fresenius Medical Care AG Forecast

Price Target

By TipRanks

5.36% upside

12 Months Forecast

Average 37.54 EUR  5.36%

High 50 EUR

Low 26 EUR

Based on 12 Wall Street analysts offering 12 month price targets forFresenius Medical Care AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

2

Buy

6

Hold

4

Sell

Technical Score

By Trading Central

34.84 / 35.8Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

278 / 365 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.